Higher thyroid stimulating hormone leads to cardiovascular disease and an unfavorable lipid profile: EVidence from multi-cohort Mendelian randomization and metabolomic profiling. (August 2021)

• Record Type: Journal Article
• Authors: Van Vliet, N.A.; Bos, M.M.; Thesing, C.S.; Chaker, L.; Pietzner, M.; Houtman, E.; Neville, M.J.; Li-Gao, R.; Trompet, S.; Mustafa, R.; Ahmadizar, F.; Beekman, M.; Bot, M.; Budde, K.; Christodoulides, C.; Dehghan, A.; Delles, C.; Elliott, P.; Evangelou, M.; Gao, H.; Ghanbari, M.; Van Herwaarden, A.E.; Ikram, M.A.; Jaeger, M.; Jukema, J.W.; Karaman, I.; Karpe, F.; Kloppenburg, M.; Meessen, J.M.T.A.; Meulenbelt, I.; Milaneschi, Y.; Mooijaart, S.P.; Mook-Kanamori, D.O.; Netea, M.G.; Netea-Maier, R.T.; Peeters, R.P.; Penninx, B.W.J.H.; Sattar, N.; Slagboom, P.E.; Suchiman, H.E.D.; Völzke, H.; Van Dijk, K. Willems; Noordam, R.;
• Is Part Of: Atherosclerosis. Volume 331(2021)
• Page Start: e40
• Publication Date: 2021-08
• Subjects: Arteriosclerosis -- Periodicals; Electronic journals; 616.136
• DOI: 10.1016/j.atherosclerosis.2021.06.114
• Languages: English
• ISSNs: 0021-9150